Trials / Sponsors / Tigris Pharmaceuticals
Tigris Pharmaceuticals
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Study of AFP464 +/- Faslodex in ER + Breast Cancer Breast Neoplasm | Phase 2 | 2011-05-01 |
| Withdrawn | Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer Breast Neoplasm | Phase 2 | 2010-04-01 |
| Completed | A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL) Cervical Intraepithelial Neoplasia, Uterine Cervical Dysplasia | Phase 2 | 2007-11-01 |
| Completed | Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL Cervical Intraepithelial Neoplasia, Uterine Cervical Dysplasia | Phase 2 | 2006-01-01 |